These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33550691)

  • 41. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
    Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
    BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL; Stewart J; Issa M; Lake B; Melis R
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study.
    Kornfeld H; West K; Kane K; Kumpatla S; Zacharias RR; Martinez-Balzano C; Li W; Viswanathan V
    Chest; 2016 Jun; 149(6):1501-8. PubMed ID: 26973015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients.
    Restrepo BI
    Tuberculosis (Edinb); 2016 Dec; 101S():S69-S72. PubMed ID: 27720378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
    Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
    BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of metformin failure in gestational diabetes mellitus (GDM).
    Khin MO; Gates S; Saravanan P
    Diabetes Metab Syndr; 2018 May; 12(3):405-410. PubMed ID: 29576523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
    DeFronzo RA; Goodman AM
    N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
    Bulatova N; Kasabri V; Qotineh A; Al-Athami T; Yousef AM; AbuRuz S; Momani M; Zayed A
    Diabetes Metab Syndr; 2018 May; 12(3):257-267. PubMed ID: 29221717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents: results of a prospective, randomised study.
    Zawiejska A; Wender-Ozegowska E; Grewling-Szmit K; Brazert M; Brazert J
    J Physiol Pharmacol; 2016 Apr; 67(2):227-33. PubMed ID: 27226182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
    Seufert J; Pegelow K; Bramlage P
    Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
    Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
    Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.
    Bailey CJ; Bagdonas A; Rubes J; McMorn SO; Donaldson J; Biswas N; Stewart MW
    Clin Ther; 2005 Oct; 27(10):1548-61. PubMed ID: 16330291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
    Malone JK; Kerr LF; Campaigne BN; Sachson RA; Holcombe JH;
    Clin Ther; 2004 Dec; 26(12):2034-44. PubMed ID: 15823767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.
    Ma Y; Pang Y; Shu W; Liu YH; Ge QP; Du J; Li L; Gao WW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1259-1263. PubMed ID: 29679254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.